Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Non Operating Investment Income (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Non Operating Investment Income for 5 consecutive years, with -$10000.0 as the latest value for Q1 2020.

  • On a quarterly basis, Non Operating Investment Income fell 124.39% to -$10000.0 in Q1 2020 year-over-year; TTM through Mar 2020 was -$18000.0, a 114.29% decrease, with the full-year FY2019 number at $33000.0, up 200.0% from a year prior.
  • Non Operating Investment Income was -$10000.0 for Q1 2020 at Forte Biosciences, up from -$33000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $54000.0 in Q2 2018 to a low of -$74000.0 in Q1 2018.
  • A 5-year average of $285.71 and a median of -$3500.0 in 2017 define the central range for Non Operating Investment Income.
  • Biggest YoY gain for Non Operating Investment Income was 1000.0% in 2018; the steepest drop was 7300.0% in 2018.
  • Forte Biosciences' Non Operating Investment Income stood at -$9000.0 in 2016, then crashed by 244.44% to -$31000.0 in 2017, then surged by 200.0% to $31000.0 in 2018, then crashed by 206.45% to -$33000.0 in 2019, then skyrocketed by 69.7% to -$10000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Non Operating Investment Income are -$10000.0 (Q1 2020), -$33000.0 (Q4 2019), and -$13000.0 (Q3 2019).